Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estetrol therapy in primary Sjögren's syndrome
2007-003537-16Phase 2Active
- Sponsor
- Erasmus MC
- Start
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of estetrol in primary Sjögren's syndrome, sponsored by Erasmus MC. Primary endpoints: Composite meaningful improvement across 2 of 3 Sjögren's syndrome domains, Oral domain improvement and 2 more. Started Aug 2007; status: active.
02
Drugs
estetrol
03
Conditions
primary Sjögren's syndrome
Beyond the preview
Go deeper on 2007-003537-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003537-16.